Bloomberg Johnson & Johnson agreed to buy Actelion Ltd. for $30 billion and spin off the Swiss drugmaker’s research and development operations, clinching its largest deal ever to become a leader in medicines for a rare type of high blood pressure. J&J, already the world’s biggest maker of health-care products, is fulfilling its goal of gaining a new drug …

  Bloomberg To convince investors to finance a pan-European war against Uber Technologies Inc., a French ride-hailing app 50 times smaller has a one-word pitch: profit. Chauffeur-Prive is near closing a 50-million-euro ($53 million) fundraising round to expand out of Paris into the rest of Europe, with the promise it can extend a five-year streak of growth while turning a …

  Bloomberg Fiat Chrysler Automobiles NV expects debt to fall by at least 45 percent this year as the Italian-American carmaker enters the final stretch of a plan to turn liabilities into cash by selling more expensive autos. The stock jumped. Net industrial debt will narrow to less than 2.5 billion euros ($2.7 billion) this year from 4.6 billion euros …